Speaker illustration

Miss Jiayan Zhang

Manchester (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology
Heart Failure Association

EDEM2 is a new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2

Event: Heart Failure 2025

Topic: Pathophysiology and Mechanisms

Session: Advances in mechanisms of heart failure

Thumbnail